Position in ZTS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$103,165,952
+$35,739,796 QoQ
Shares Held
1,435,652
+151.7% QoQ
Ownership
0.347%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#56
of 1,412 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
923,125 | $155,583,487 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
249,056 | $134,946,012 | |
| 3 | ALKS |
Alkermes plc.
|
2,421,016 | $126,861,238 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
1,435,652 | $103,165,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,114,912 | $33,902,039 | |
| 6 | LQDA |
Liquidia Corp
|
301,432 | $24,033,173 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,120,469 | $11,204,690 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
614,206 | $10,631,905 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,165,952 | 1,435,652 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $67,426,156 | 570,393 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $198,764,648 | 1,579,754 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $217,352,360 | 1,485,459 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $52,397,952 | 335,992 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $185,731,292 | 1,128,037 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,025,533 | 104,496 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,695,582 | 44,506 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $21,532,005 | 124,204 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $23,413,756 | 138,371 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $20,456,018 | 103,643 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,606,890 | 37,975 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $16,489,796 | 95,754 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,257,307 | 73,644 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $169,029,157 | 1,153,389 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $150,511,680 | 1,014,982 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $169,457,240 | 985,847 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $202,952,071 | 1,076,155 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $247,671,903 | 1,014,924 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $186,271,699 | 959,471 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $191,428,432 | 1,027,197 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $152,725,041 | 978,399 | Shares | Other | 2021-05-14 | |
| 2020-12-31 | $204,546,911 | 1,235,933 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $193,783,873 | 1,171,820 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $166,159,629 | 1,212,490 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $133,017,004 | 1,130,232 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||